Meredith Cook Ani Pharmaceuticals Inc (ANIP) insider trading activity

Meredith Cook is SR. VP, GENERAL COUNSEL & SEC. of ANI PHARMACEUTICALS INC. Currently has a direct ownership of 55,588 shares of ANIP, which is worth approximately $3.29 Million. The most recent transaction as insider was on Jan 13, 2025, when has been sold 400 shares (Common Stock) at a price of $53.92 per share, resulting in proceeds of $21,568. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 55.6K

1.59% 3M change

50.04% 12M change

Total Value Held $3.29 Million

Meredith Cook Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 13 2025	SELL Open market or private sale	$21,568 $53.92 p/Share	400 Reduced 0.71%	55,588 Common Stock
Dec 13 2024	SELL Open market or private sale	$14,060 $56.24 p/Share	250 Reduced 0.44%	55,988 Common Stock
Nov 13 2024	SELL Open market or private sale	$15,340 $61.36 p/Share	250 Reduced 0.44%	56,238 Common Stock
Oct 14 2024	SELL Open market or private sale	$14,297 $57.19 p/Share	250 Reduced 0.44%	56,488 Common Stock
Sep 13 2024	SELL Open market or private sale	$14,205 $56.82 p/Share	250 Reduced 0.44%	56,738 Common Stock
Aug 13 2024	SELL Open market or private sale	$14,905 $59.62 p/Share	250 Reduced 0.44%	56,988 Common Stock
Jul 18 2024	SELL Payment of exercise price or tax liability	$106,933 $61.35 p/Share	1,743 Reduced 2.96%	57,238 Common Stock
Jul 12 2024	SELL Open market or private sale	$16,227 $64.91 p/Share	250 Reduced 0.42%	58,981 Common Stock
Jun 13 2024	SELL Open market or private sale	$15,950 $63.8 p/Share	250 Reduced 0.42%	59,231 Common Stock
May 13 2024	SELL Open market or private sale	$16,922 $67.69 p/Share	250 Reduced 0.42%	59,481 Common Stock
Apr 12 2024	SELL Open market or private sale	$16,947 $67.79 p/Share	250 Reduced 0.42%	59,731 Common Stock
Mar 13 2024	SELL Open market or private sale	$16,635 $66.54 p/Share	250 Reduced 0.42%	59,981 Common Stock
Feb 29 2024	SELL Payment of exercise price or tax liability	$79,376 $67.67 p/Share	1,173 Reduced 1.91%	60,231 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	24,605 Added 28.61%	61,404 Common Stock
Feb 13 2024	SELL Open market or private sale	$14,010 $56.04 p/Share	250 Reduced 0.67%	36,799 Common Stock
Jan 12 2024	SELL Open market or private sale	$14,107 $56.43 p/Share	250 Reduced 0.67%	37,049 Common Stock
Dec 11 2023	SELL Open market or private sale	$12,302 $49.21 p/Share	250 Reduced 0.67%	37,299 Common Stock
Nov 13 2023	SELL Open market or private sale	$13,007 $52.03 p/Share	250 Reduced 0.66%	37,549 Common Stock
Jul 18 2023	SELL Payment of exercise price or tax liability	$90,444 $51.89 p/Share	1,743 Reduced 4.41%	37,799 Common Stock
Feb 28 2023	BUY Grant, award, or other acquisition	-	20,262 Added 33.88%	39,542 Common Stock
Jul 18 2022	BUY Grant, award, or other acquisition	-	19,280 Added 50.0%	19,280 Common Stock

Meredith Cook

SR. VP, GENERAL COUNSEL & SEC.

Baudette, MN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANIP shares.

Notify only if

Value

Insider Trading

Get notified when an Ani Pharmaceuticals Inc insider buys or sells ANIP shares.

Notify only if

Operation

Value

Type

News

Receive news related to ANI PHARMACEUTICALS INC

Track Activities on ANIP

Account